Beam (BEAM) has been decreasing since reaching an all-time high price on April 11. Despite the drop, BEAM has validated the previous breakout level as support. It is expected to bounce from this ...
Breaking up ain’t hard to do. The celebration of Beam’s chart is more than a one day spike – it is years of value creation ...
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed.